ninjawarrioruk| Kangfang Biotech's share price fluctuated sharply: Hong Kong stock biotechnology stocks suffered a setback, with the largest decline of 45%
editor 2024-05-24 11:11:37 Home 42
News summary
Newsletter text
Kangfang Biotech's share price suffered, triggering a collective decline in Hong Kong stock biotechnology stocks
On May 24, Kangfang Biotech's share price was due to a report that "clinical data fell short of expectations"ninjawarriorukMarket rumors were hit hard, causing its share price to drop nearly 45% during the trading day. This negative news quickly spread to the Hong Kong stock market, causingninjawarriorukThere has been a series of chain reactions among biotechnology companies. Lepu Biotech's share price fell by more than 11%, and the shares of Columbotai Biotech, Baiji Shenzhou and Kingsressen also fell by more than 8%. In addition, the shares of Rongchang Biotech and Zaiding Pharmaceutical also fell by more than 7%, while the shares of Keji Pharmaceutical and Konoia fell by more than 6%. Lycea Pharmaceutical's share price was also not spared, falling more than 5%.